Anti cancer drug hopeful Pharmaust has appointed expert medical research company GenScript to take the trialling of their exciting anticancer drug PPL-1 to the next level. GenScript will trial the company's PPL-1 drug in animals in conjunction with standard care drugs that are usually prescribed for each particular type of cancer. The company is looking to ensure there is no adverse reaction when mixing their drug with others,
Related Data & Insights
-
-
Rank Company Revenue th PharmAust $842k 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
21 Jun 2024
PharmAust taps investors for $10m
31 May 2024
Shares rise following Thurn return
17 May 2024
Board Moves May 17, 2024
17 May 2024
PharmAust receives FDA approval
24 Apr 2024
Board Moves, April 24 2024
23 Apr 2024
PharmAust CEO resigns
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX